These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 33017280)

  • 1. COVID-19: Between Past and Present.
    Assaf AM; Haddadin RN; Akour AA
    Viral Immunol; 2021 Apr; 34(3):145-157. PubMed ID: 33017280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics.
    Ebrahimi N; Aslani S; Babaie F; Hemmatzadeh M; Hosseinzadeh R; Joneidi Z; Mehdizadeh Tourzani Z; Pakravan N; Mohammadi H
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107082. PubMed ID: 33068865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.
    Asrani P; Hasan GM; Sohal SS; Hassan MI
    OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surviving the Rookie Virus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): The Immunopathology of a SARS-CoV2 Infection.
    Tsai SF; Lu KY; Chuang HM; Liu CA
    Cell Transplant; 2021; 30():963689721993769. PubMed ID: 33840257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS 2 human coronavirus (COVID -19, SARS CoV2).
    McFee RB
    Dis Mon; 2020 Sep; 66(9):101063. PubMed ID: 32807536
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytokine storm of a different flavour: The different cytokine signature of SARS-CoV-2, the cause of COVID-19, from the original SARS outbreak.
    Griffin DO; Jensen A; Khan M; Chin J; Chin K; Saad J; Parnell R; Awwad C; Patel D
    J Glob Antimicrob Resist; 2021 Mar; 24():90-92. PubMed ID: 33242672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.
    Atzrodt CL; Maknojia I; McCarthy RDP; Oldfield TM; Po J; Ta KTL; Stepp HE; Clements TP
    FEBS J; 2020 Sep; 287(17):3633-3650. PubMed ID: 32446285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.
    Guo YR; Cao QD; Hong ZS; Tan YY; Chen SD; Jin HJ; Tan KS; Wang DY; Yan Y
    Mil Med Res; 2020 Mar; 7(1):11. PubMed ID: 32169119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses.
    O'Connell P; Aldhamen YA
    Hum Vaccin Immunother; 2020 Dec; 16(12):2980-2991. PubMed ID: 32878546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.
    Gulati A; Pomeranz C; Qamar Z; Thomas S; Frisch D; George G; Summer R; DeSimone J; Sundaram B
    Am J Med Sci; 2020 Jul; 360(1):5-34. PubMed ID: 32620220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
    Wooding DJ; Bach H
    Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases.
    Barth RF; Buja LM; Barth AL; Carpenter DE; Parwani AV
    Arch Pathol Lab Med; 2021 Oct; 145(10):1194-1211. PubMed ID: 34232978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Involvement of COVID-19: A Comprehensive Review.
    Chang WT; Toh HS; Liao CT; Yu WL
    Am J Med Sci; 2021 Jan; 361(1):14-22. PubMed ID: 33187633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of COVID-19 on the Cardiovascular System: A Review of Available Reports.
    Soumya RS; Unni TG; Raghu KG
    Cardiovasc Drugs Ther; 2021 Jun; 35(3):411-425. PubMed ID: 32926272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic.
    Kaushik P; Kaushik M; Parveen S; Tabassum H; Parvez S
    Mol Neurobiol; 2020 Dec; 57(12):4921-4928. PubMed ID: 32813238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing therapeutic strategies to combat severe acute respiratory syndrome coronavirus-2 disease: COVID-19.
    Rohilla S
    Drug Dev Res; 2021 Feb; 82(1):12-26. PubMed ID: 33216381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.